Contribution
I was just coming to that—the hon. Gentleman has obviously started to read my notes from a distance. I am aware that he met representatives of the previous Government to discuss the possibility of a satellite unit in his local area. The situation is the same now as it was then: it is the responsibility of the integrated care board, but if the hon. Gentleman thinks it would be helpful for us to have a meeting and see if we can push that case, my door is open. I absolutely recognise that people in that part of Cumbria would prefer to have those services closer to where they live. If we can impress that on his local ICB, let us see if we can make progress.
The Government aim to ensure that each treatment centre is accessible to the highest possible number of patients, as well as easily reached by the staff who work there. That is another consideration—it is not just the patients who have to physically get to these units, but the staff. We recognise that for those in rural communities, machinery may not be available at their local hospital, meaning that the only option is travel to specialist centres to receive the best possible care. Radiotherapy service provision is agreed by local systems, and each patient’s care needs and treatment location are decided on a case-by-case basis by their clinicians. We are giving local systems greater flexibility and control, as they are best placed to understand and meet the needs of their communities, but to drive the national cancer plan forward, we have to tackle this postcode lottery and the deserts head-on.
Accessibility is also about making sure that we have the right workforce available to deliver the treatment in the right places and at the right time. That is why the number of training places has increased, and it is why we are improving the quality of education for assistant practitioners, diagnostics and therapeutic radiographers. NHS England is also working to improve the retention of radiographers and radiologists through initiatives such as increasing investment in career development. By ensuring our workforce feels supported, we put ourselves in a better position to deliver the care that people need.
Turning to investment in machines, I agree with the hon. Member for Westmorland and Lonsdale that we should be ambitious in our plans to ensure that patients are treated as quickly as possible. Lord Darzi’s report highlighted the scale of the challenge we face: under the previous Government, waiting times for treatment increased, and more than 30% of patients waited longer than 31 days for radical radiotherapy.
In response to Lord Darzi’s findings, we have taken urgent action to get the NHS back on its feet. At the recent Budget, my right hon. Friend the Chancellor supported our commitment to end the backlogs by announcing £70 million of investment in new radiotherapy machines in 2025-26. Replacing older radiotherapy machines with newer, more efficient and more technically advanced ones will ensure that patients can be seen more quickly. By doing so, we will improve access and speed up cancer treatment. Making more advanced machines available means that patients will have fewer trips to receive their treatment.
Hon. Members may be aware that NHS England has now allocated funding to trusts across the country to purchase the new radiotherapy machines with the £70 million investment. NHS England invited trusts to express interest in receiving funding to purchase a new machine. Allocation criteria focused on the age of the machine being replaced, the proportion of older machines in use in the trust and the trust’s performance on radiotherapy. We expect to fund at least 27 new machines, which should be available to treat patients by spring 2026.
Those steps will ensure that we can improve cancer waiting times as soon as possible, helping us to put an end to the last Government’s neglect and underinvestment. I reassure the hon. Member for Westmorland and Lonsdale, and other hon. Members, that we will continue to make the case for additional funding, so that we can continue to upgrade machines and push the advances of the latest technological developments, for the benefit of patients with cancer.
I turn to the national cancer plan. Beyond immediate actions, we know that bold reform is required to rise to the growing challenge that cancers of all types represent. Lord Darzi found that cancer survival in this country is worse than in comparable countries, and that improvement slowed greatly during the 2010s. To help us to develop more targeted actions, my right hon. Friend the Secretary of State has announced the development of a national cancer plan, which was the subject of the statement I gave in the House just a few hours ago. The overarching aim of the plan is to reduce the number of lives lost to cancer. It will detail how we will improve outcomes for cancer patients, ensuring that patients have access to the most effective treatments and technology, including radiotherapy.
Today, we launched our national cancer plan call for evidence. We welcome views from all hon. and right hon. Members, as well as from clinicians, patients and their families—it is critical that we get the views of people who have lived experience of accessing cancer care—charities, researchers, members of the public and, of course, the excellent all-party parliamentary groups that champion cancer treatment and outcomes in this House.
In closing, I thank the hon. Member for Westmorland and Lonsdale for bringing this crucial matter to the House. I thank hon. Members, whose contributions have, in the spirit of this year’s World Cancer Day, put places and people at the centre of care. I am pleased to assure hon. Members that we are undertaking both immediate actions and bold reforms to improve access to radiotherapy. There is a lot more that we need to do, and we will do it in partnership. This work is part of our effort to rebuild the NHS and deliver world-class cancer services for everybody—something that will always be a top priority for this Government and that is personal for me—so let’s get on and achieve it.